|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.
CORT $11.17 -0.66 (-5.58%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 1.28 Billion
EPS 0.19 P/E Ratio 18.62
Previous Earnings Thu, Aug 9, 2018
Latest Earnings Thu, Nov 1, 2018
Dividend Pay Date --
Dividend History --
Investing Quotes #Legendary
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.